When was DEMENEGO acquired by VAM INVESTMENTS?

DEMENEGO was acquired by VAM INVESTMENTS in 2020.

What was the revenue of DEMENEGO at the time of the deal?

The revenue of DEMENEGO at the time of the deal is estimated to be in the range of 10M - 30M EUR.

What was the EBITDA of DEMENEGO during the acquisition?

DEMENEGO's EBITDA is estimated to be in the range of 5M - 25M EUR.

How is the data for the DEMENEGO acquisition sourced and is it reliable?

Mynth data is contributed by a professional community of M&A and Private Equity experts. Each transaction, including the DEMENEGO deal, is systematically cross-verified by our team using private deal documents and official sources. You can also find the official press release for this transaction here: https://www.vaminvestments.com/wp-content/uploads/2023/06/Demenego-Press-Release-December-2020.pdf.pdf

← DATABASE

Home Database Healthcare & PharmaDEMENEGO

09/2020

DEMENEGO acquired by VAM INVESTMENTS

ITALY Health Providers / Outpatient Care / Ophthalmology REV 10M - 30M EUR

Context

VAM Investments acquired an 80% majority stake in Demenego from the founding De Menego family. This primary buyout transaction was designed to facilitate the transition of the company from a family-run business to a managerially-led retail platform. The founding family reinvested to retain a 20% minority stake, ensuring a smooth leadership handover. The strategic rationale for the deal centers on accelerating the growth of the store network and professionalizing the corporate structure.

DEMENEGO, which reported an EBITDA margin of in 2019, is valued in this transaction at an EV/EBITDA multiple of , a level to compare with the average currently observed in the Healthcare & Pharma sector (15.6x).

-> Deep-dive in Healthcare & Pharma market trends

Target

Founded in 1960, Demenego is a historic Italian eyewear specialist and a leading chain of specialized optical centers in North-East Italy. The company operates a network of 39 stores and employs approximately 270 people, serving a loyal database of 630,000 registered clients. Its unique business model integrates high-level healthcare services with retail excellence, featuring state-of-the-art medical equipment for vision correction in every location. A distinctive innovation is the presence of "Demenego Labs" in all sales points, which utilize interconnected digital systems to produce customized glasses in just one hour. The group offers a vast range of over 4,500 models, combining its successful private label with major international third-party brands to ensure visual well-being and a modern omnichannel shopping experience.

Ent. Value

Equity Value

Multiples

EV / Revenue

EV / EBITDA

EV / EBIT

Historical Financials (EUR)

Year

Rev

EBITDA

EBIT

2019

2018

Other operations with DEMENEGO

List of similar M&A transactions (Date, Acquirer, Target, Country, Sub-sector)
Date	Acquirer	Target	Country	Sector
10/2024	MONTEFIORE INVESTMENT	DEMENEGO	ITALY	Ophthalmology

REFERENCES

Revenue range: 10M - 30M EUR

EBITDA range: 5M - 25M EUR

Note: This page provides detailed data on a private equity M&A transaction. Detailed and exact financial metrics for the acquisition of DEMENEGO by VAM INVESTMENTS are reserved for mynth community members. Register for free to unlock full data.

Authors: This transaction was contributed by a verified mynth contributor and cross-checked against available transaction documents and official company communications.

Press release: view release

Acquirer: vam investments